Factbox: Most short-lived SPAC deals of 2022
Aug 10 (Reuters) - Several startups have ditched their deals
with blank-check companies this year, spooked by wobbly
financial markets as the Federal Reserve tightens its monetary
policy.
One of the hallmarks of pandemic-era deal-making, special
purpose acquisition companies, or SPACs, became hugely popular
among companies looking to list their shares by avoiding the
scrutiny and hurdles of a regular initial public offering.
Here are the 10 most short-lived SPAC deals that collapsed
in 2022:
SPAC Intended Number of Deal value
target days between
announcement
and withdrawal
Aesther United 53 Undisclosed
Healthcare Gear &
Acquisition Assembly
Corp Inc
Mudrick Blue Nile 55 $450 mln
Capital Inc
Acquisition
Corp II
Isleworth Cytovia 65 $325 mln
Healthcare Inc
Acquisition
Corp
Atlantic Essentium 72 $1.14 bln
Coastal Inc
Acquisition
Corp
Fortune VCV 79 $350 mln
Rise Digital
Acquisition Technolog
Corp y LLC
FoxWayne Aerami 87 $250 mln
Enterprises Therapeut
Acquisition ics Inc
Corp
Pine Tomorrow 90 $700 mln
Technology Companies
Acquisition Inc
Corp
Rosecliff Gett Inc 121 $951 mln
Acquisition
Corp I
Silver Eleusis 140 $412 mln
Spike Holdings
Acquisition Ltd
Corp II
Sports Double 142 $1.32 bln
Ventures Negative
Acquisition Ltd
Corp
Source: Dealogic
(Reporting by Niket Nishant in Bengaluru; Editing by Anil
D'Silva)
((Niket.Nishant@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device